Adipose tissue surrounding the great vessels [perivascular (PV) adipose tissue, or PVAT] expands during obesity, is highly inflamed and correlates with coronary plaque burden and increased cardiovascular (CV) risk. A consensus is emerging that PVAT is a cause of CV disease, but direct proof is lacking. Demonstrating a pathogenic role for PVAT challenges the current paradigm that CV disease originates primarily at the intima and provides a new target for assessment and treatment of CV disease. Our laboratory has developed a robust model of PVAT transplantation to the mouse carotid artery to determine its role in eliciting vascular pathology and the mechanisms whereby PVAT interacts with metabolic factors, chemokines, inflammatory cells and the blood vessel wall. PVAT transplantation in the setting of high fat diet dramatically enhanced wire injury- induced neointimal formation and atherosclerosis, and increased adventitial inflammation and angiogenesis, providing direct evidence that PVAT plays a pathogenic role in CVD. Moreover, preliminary data suggest that transplanting PVAT from mice lacking the chemokine MCP-1 attenuates neointimal formation, consistent with pleiotropic effects of MCP-1 to promote vascular remodeling. In addition, angiotensin II (AngII) is upregulated in adipose tissue during high fat feeding and promotes adventitial remodeling and inflammation. Our central hypothesis is that PVAT synergizes with high-fat diet and AngII to enhance arterial remodeling and atherosclerosis, in part through secretion of MCP-1. To test this hypothesis, we propose three specific aims.
Aim 1 will test the hypothesis that high-fat diet and AngII synergize with PVAT to enhance arterial remodeling and atherosclerosis, using PVAT from wild-type mice or AngII receptor type-1a (AT1a) knockout mice.
Aim 2 will test the hypothesis that stromal-derived factor 1? (SDF-1?), which increases in the intima and media soon after wire injury, is requisite for "inside-out" molecular crosstalk leading to enhanced arterial remodeling by PVAT.
Aim 3 will test the hypothesis that MCP-1 secretion by PVAT is requisite for "outside-in" molecular crosstalk leading to enhanced arterial remodeling and atherosclerosis by PVAT. Using PVAT from wild-type or MCP-1 knockout mice, we will investigate an interactive role of AngII with MCP-1 in these experiments. The proposed studies are expected to provide direct evidence of a pathogenic role of PVAT in CVD, to define interactions between PVAT, high-fat diet and AngII, and to address putative molecular mechanisms of crosstalk between the blood vessel wall and PVAT.
The purpose of this study is to determine the role of fat that surround blood vessels also known as perivascular adipose tissue, or PVAT) in causing vascular disease. We provide evidence that the inside of the blood vessel (intima) communicates with the PVAT when the artery is injured, leading to increased obstruction of the blood vessel. We plan to determine what mediates this communication system and how it is perturbed in the setting of high fat diet.
|Campbell, C R; Berman, A E; Weintraub, N L et al. (2016) Electrical stimulation to optimize cardioprotective exosomes from cardiac stem cells. Med Hypotheses 88:6-9|
|Li, Jie; Ma, Wenxia; Yue, Guihua et al. (2016) Cardiac proteasome functional insufficiency plays a pathogenic role in diabetic cardiomyopathy. J Mol Cell Cardiol 102:53-60|
|Kim, Ha Won; Weintraub, Neal L (2016) Aortic Aneurysm: In Defense of the Vascular Smooth Muscle Cell. Arterioscler Thromb Vasc Biol 36:2138-2140|
|Zhou, Hongyi; Black, Stephen M; Benson, Tyler W et al. (2016) Berardinelli-Seip Congenital Lipodystrophy 2/Seipin Is Not Required for Brown Adipogenesis but Regulates Brown Adipose Tissue Development and Function. Mol Cell Biol 36:2027-38|
|Romero, Maritza J; Lucas, Rudolf; Dou, Huijuan et al. (2016) Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes. Proc Natl Acad Sci U S A 113:1895-900|
|Teoh, Jian-Peng; Park, Kyoung-Mi; Broskova, Zuzana et al. (2015) Identification of gene signatures regulated by carvedilol in mouse heart. Physiol Genomics 47:376-85|
|Collins, Sean P; Jenkins, Cathy A; Harrell Jr, Frank E et al. (2015) Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool. JACC Heart Fail 3:737-47|
|Yiew, Kan Hui; Chatterjee, Tapan K; Hui, David Y et al. (2015) Histone Deacetylases and Cardiometabolic Diseases. Arterioscler Thromb Vasc Biol 35:1914-9|
|Wang, Yingjie; Zhang, Lan; Li, Yongjun et al. (2015) Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol 192:61-9|
|Xu, Jialin; Donepudi, Ajay C; More, Vijay R et al. (2015) Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin-deficient mice. Obesity (Silver Spring) 23:335-44|
Showing the most recent 10 out of 46 publications